Signaling Pathway
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20677 | UJN49930 ( UGT8-IN-1 ) | 2414349-93-0 | ≧98.0% | _2414349-93-0.png) |
| UJN49930 ( UGT8-IN-1 ) is an inhibitor of UDP-galactose ceramide galactosyltransferas | ||||
| 24021 | SY-008 | 1480443-32-0 | ≧98.0% |  |
| SY-008 is a sodium glucose transporter 1 (SGLT1) inhibitor. | ||||
| 24016 | SY-008 Acetate | 1878218-66-6 | ≧98.0% |  |
| SY-008 is a sodium glucose transporter 1 (SGLT1) inhibitor. | ||||
| 24024 | CVN-293 | 2815296-08-1 | ≧98.0% |  |
| CVN-293 is an oral, brain-penetrant, small-molecule inhibitor of KCNK13. | ||||
| 24026 | AMXT-1501 ( AMX-513 ) | 441022-64-6 | ≧98.0% | _441022-64-6.png) |
| AMXT-1501 ( AMX-513 ) is a novel inhibitor of the polyamine transport system. AMXT150 | ||||
| 24028 | Golidocitinib ( AZD-4205 ) | 2091134-68-6 | ≧98.0% | _2091134-68-6.png) |
| Golidocitinib (AZD-4205) is an oral JAK1 selective kinase inhibitor. | ||||
| 24029 | IMP-1088 | 2059148-82-0 | ≧98.0% |  |
| IMP-1088 is a potenthuman N-myristoyltransferases NMT1andNMT2dual inhibitor. | ||||
| 24038 | NNC-55-0396 | 357400-13-6 | ≧98.0% |  |
| NNC-55-0396 is a highly selective T-type calcium channel blocker which can be used fo | ||||
| 24039 | Ladarixin | 849776-05-2 | ≧98.0% |  |
| Ladarixin (DF-2156 ; DF-2156A) is an orally active, allosteric non-competitive and du | ||||
| 24040 | KB-0742 | 2416873-83-9 | ≧98.0% |  |
| KB-0742 is a Potent, Selective, Orally Bioavailable Small Molecule Inhibitor of CDK9 | ||||
| 24041 | ASN-90 ( ASN-120290, FNP-223 ) | 2129093-74-7 | ≧98.0% |  |
| ASN-90 (ASN-120290, FNP-223) is an oral, brain-penetrant, small-molecule inhibitor of | ||||
| 24042 | SPG-601 ( VSN-16R ) | 863713-78-4 | ≧98.0% |  |
| SPG-601 (formerly VSN-16R) is an orally available cannabinoid receptor agonist. | ||||